This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of our studies is to determine whether CAM modalities can improve disease progression or the quality of life or for cancer patients. Anxiety is reported more often than any other psychological symptom in patients with or surviving cancer. Cnxiety is of concern as it has been implicated in cancer progression. Current methods of anxiety reduction include medication and psychosocial interventions that requrie active mental engagement by the patient. A CAM modality used frequently by cancer patients is spirituality. One modality based on spirituality is entergy-healing. While clients often claim decreased anxiety following energy-healing, this has not been rigorously tested. Studies of the beneficial effects of energy-healing on disease states have been inconclusive and relied mainly on non-physiological outcome measures.
Our aim was to design a study to determine whether energy-healing affects disease progression or anxiety in a cancer population, using physiological markers of outcome. Prostate cancer is a disease in which there is a serum marker for tumor progression, prostate specific antigen (PSA). Prostate cancer is also associated with hihg anxiety. The present application represents collaboration between physicians, basic scientists, psychiatrists, biostaticians, and energy healters. We propose a pilot study in which newly diagnosed prostate cancer patients will be provided with energy-healing treatments for 4-weeks during the 6-8 week period between initial diagnosis and radical prostatectomy. PSA levels will be used to assess disease progression. Anxiety states will be moniotred using salivary cortisol and DHEA assays as well as serum atrial natriuretic peptide (ANP) levels in addition to validated psychometric instruments.
The Specific Aims are: 1) to detrimine the effects of energy-healing on cancer activity as measured by PSA levels in the blood, 2) to determine the effects of energy-healing on anxiety states using validated psychometric instruments, 3) to determine the effects of energy-healing on physiologic anxiety as measured by cortisol, DHEA and ANP levels. By incorporating no-treatment, sham healing, and Reiki treatment groups, we will determine whether any effects observed could also be obtained by a sham healer. We anticipate that these studies will provide insights into whether energy-healing holds promise as an adjunct to standard

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR018390-04
Application #
7377707
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2006-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
4
Fiscal Year
2006
Total Cost
$80,883
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Rose, Jonathan A; Wanner, Nicholas; Cheong, Hoi I et al. (2016) Flow Cytometric Quantification of Peripheral Blood Cell ?-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension. PLoS One 11:e0156940
Kasumov, Takhar; Solomon, Thomas P J; Hwang, Calvin et al. (2015) Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes. Obesity (Silver Spring) 23:1414-21
Alkhouri, N; Eng, K; Cikach, F et al. (2015) Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls. Pediatr Obes 10:23-9
Rose, Jonathan A; Erzurum, Serpil; Asosingh, Kewal (2015) Biology and flow cytometry of proangiogenic hematopoietic progenitors cells. Cytometry A 87:5-19
Naples, Robert; Laskowski, Dan; McCarthy, Kevin et al. (2015) Carboxyhemoglobin and methemoglobin in asthma. Lung 193:183-7
Wu, Wei; Bleecker, Eugene; Moore, Wendy et al. (2014) Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 133:1280-8
Li, Xingnan; Hawkins, Gregory A; Ampleford, Elizabeth J et al. (2013) Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 132:313-20.e15
Asosingh, Kewal; Farha, Samar; Lichtin, Alan et al. (2012) Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. Blood 120:1218-27
Yip, Kathleen; Heinberg, Leslie; Giegerich, Victoria et al. (2012) Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery. Obes Surg 22:1723-9
Li, Xingnan; Ampleford, Elizabeth J; Howard, Timothy D et al. (2012) Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 130:861-8.e7

Showing the most recent 10 out of 136 publications